Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Victoria Probst"'
Publikováno v:
The Journal of Liquid Biopsy, Vol 4, Iss , Pp 100146- (2024)
As precision oncology has become a major part of the treatment landscape in oncology, liquid biopsies have developed as a particularly powerful tool as it surmounts several limitations of traditional tissue biopsies. These biopsies involve most commo
Externí odkaz:
https://doaj.org/article/531263ab01894590b7c4b2496dfd6346
Autor:
Victoria Probst, Arman Simonyan, Felix Pacheco, Yuliu Guo, Finn Cilius Nielsen, Frederik Otzen Bagger
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background Single cell mRNA sequencing technologies have transformed our understanding of cellular heterogeneity and identity. For sensitive discovery or clinical marker estimation where high transcript capture per cell is needed only plate-
Externí odkaz:
https://doaj.org/article/3fc2aef8910241feb171873744691636
Publikováno v:
Clinical Immunology Communications, Vol 1, Iss , Pp 4-12 (2021)
Myasthenia gravis (MG) is an autoimmune disease characterised by muscular degeneration and autoantibodies to components of the neuromuscular junction. Development of MG is thought to occur from a combination of genetic and environmental factors, and
Externí odkaz:
https://doaj.org/article/a0bc5f33a252457ca854ba44305374d4
Autor:
Bagger, Victoria Probst, Lotte Møller Smedegaard, Arman Simonyan, Yuliu Guo, Olga Østrup, Kia Hee Schultz Dungu, Nadja Hawwa Vissing, Ulrikka Nygaard, Frederik Otzen
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10251
Improved methods are needed for diagnosing infectious diseases in children with cancer. Most children have fever for other reasons than bacterial infection and are exposed to unnecessary antibiotics and hospital admission. Recent research has shown t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::77e83f55848ae513c8f887a8a9494d02
Publikováno v:
Advances in experimental medicine and biology. 1255
Personalized medicine has been driven by improvements in genomic sequencing and analysis. For several diseases, in particular cancers, it has for nearly a decade been standard clinical practice to analyze the genome and expression of the genes of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1be736c74e7c321ae9105cb4bd158acf
https://pubmed.ncbi.nlm.nih.gov/32949400
https://pubmed.ncbi.nlm.nih.gov/32949400
Single cell mRNA sequencing technologies have transformed our understanding of cellular heterogeneity and identity. For sensitive discovery or clinical marker estimation where high transcript capture per cell is needed only plate-based techniques cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54ca70680115cd6463077bde006b821c
https://doi.org/10.1101/2020.07.29.225201
https://doi.org/10.1101/2020.07.29.225201
Autor:
Victoria Probst, Frederik Otzen Bagger
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9789811544934
Personalized medicine has been driven by improvements in genomic sequencing and analysis. For several diseases, in particular cancers, it has for nearly a decade been standard clinical practice to analyze the genome and expression of the genes of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf4a60a950960bcf23a80f37312e97fd
https://doi.org/10.1007/978-981-15-4494-1_15
https://doi.org/10.1007/978-981-15-4494-1_15
Autor:
Roela Sadushi-Kolici, Victoria Probst, Irene Lang, Ioana A Campean, Christian Gerges, Nika Skoro-Sajer
Publikováno v:
Pulmonary hypertension.
Rationale: Asymmetric dimethylarginine (ADMA) is increased in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) and associated with unfavorable outcomes. We hypothesized that ADMA may serve as a biomarker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50a859856c57b5acbae9044d4ae78455
https://doi.org/10.1183/13993003.congress-2019.oa501
https://doi.org/10.1183/13993003.congress-2019.oa501